Epithelial Ovarian Cancer Treated by Platinum or Platinum Analogue with Cyclophosphamide : Experience in Ramathibodi Hospital

Journal of the Medical Association of Thailand

Volumn 81, Issue 1, 1998, Pages 10-16

  Linasmita, Vasant ^a   Wilailak, Sarikapan ^a   Srisupundit, Somkeart ^a   Tangtrakul, Somsak ^a   Bullangpoti, Sunchai ^a   Israngura, Nathapong ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; PLATINUM; PLATINUM DERIVATIVE;

ADVANCED CANCER; ANEMIA; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CLINICAL PROTOCOL; FEMALE; HUMAN; INDIA; LEUKOPENIA; MAJOR CLINICAL STUDY; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; OVARY CANCER; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 2442679296     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Vatanasapt V, Martin N, Sriplung H, et al. Cancer in Thailand 1988-1991. IARC Technical Report No.166, International Agency for Research on Cancer, 1973.
2. Linasmita V, Sakornratanakul P, Ittisiriwait N, et al. Survival in patients treated with platinumbased combination with cyclophosphamide for advanced ovarian adenocarcinoma: Ramathibodi experience. Mahidol University Annual Research Abtracts. 1994: 33.
3. WHO Handbook for reporting results of cancer treatment. WHO Offset Publication No. 48, Geneva: World Health Organization, 1979.
4. Cannister SA. Cancer of the ovary. N Engl J Med 1993; 329: 1550-9.
5. Ozols RF, Rubin SC, Thomas G, Robboy S. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RE, eds. Principle and Practice of Gynecologic Oncology, 2nd, ed.Philadelphia, Lippincott - Raven Publisher, 1997: 924-5.
6. Link CL, Jr., Reed E, Sarosy G, Kahn EC. Borderline ovarian tumors. Am J Med 1996; 101: 217-25.
7. Pettersson F. Annual Report on the results of Treatment in Gynecological Cancer. International Federation of Gynecology and Obstetrics, Vol. 22, Stockholm, Sweden 1994.
8. Young RC, Walton LA, Ellenberg SS, et al. Adjuvant therapy in stage I and II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med 1990; 322: 1021-7.
9. Albert DS, Green S, Hannigan EV, et al. Improved therapeutic index of carboplatin plus cyclophosphamide - versus cisplatin plus cyclophosphamide : final report of the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer. J Clin Oncol 1992; 10: 706-17.
10. Swenerton KD, Pater JL. Carboplatin in the treatment of carcinoma of the ovary. The National Cancer Institute of Canada experience. Sem Oncol 1992; 19: 144-9.
11. Aabo K, Adams M, Albert DS, et al. Chemotherapy in advanced ovarian cancer: a overview of randomized clinical trials. BMJ 1991; 303: 884-93
12. Griffith CT, Parker LM, Fuller AF Jr. Role of cytoreductive surgical treatment in the management of advanced ovarian cancer. Cancer Treat Rep 1979; 63: 235-40.
13. Wharton JT, Edwards CI, Rutledge FN. Long-term survival after chemotherapy for advanced epithelial ovarian carcinoma. Am J Obstet Gynecol 1984; 148: 997-1005.
14. Omura GA, Brady MF, Homesley HD, et al. Long-term follow-up and prognostic factors analysis in advanced ovarian carcinoma. The Gynecologic Oncology Group experience. J Clin Oncol 1991; 9: 1138-50.